Flow Cytometry-Based Characterization of Mast Cells in Human Atherosclerosis

The presence of mast cells in human atherosclerotic plaques has been associated with adverse cardiovascular events. Mast cell activation, through the classical antigen sensitized-IgE binding to their characteristic Fcε-receptor, causes the release of their cytoplasmic granules. These granul...

Full description

Bibliographic Details
Main Authors: Eva Kritikou, Marie A.C. Depuydt, Margreet R. de Vries, Kevin E. Mulder, Arthur M. Govaert, Marrit D. Smit, Janine van Duijn, Amanda C. Foks, Anouk Wezel, Harm J. Smeets, Bram Slütter, Paul H.A. Quax, Johan Kuiper, Ilze Bot
Format: Article
Language:English
Published: MDPI AG 2019-04-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/8/4/334
_version_ 1827834572030607360
author Eva Kritikou
Marie A.C. Depuydt
Margreet R. de Vries
Kevin E. Mulder
Arthur M. Govaert
Marrit D. Smit
Janine van Duijn
Amanda C. Foks
Anouk Wezel
Harm J. Smeets
Bram Slütter
Paul H.A. Quax
Johan Kuiper
Ilze Bot
author_facet Eva Kritikou
Marie A.C. Depuydt
Margreet R. de Vries
Kevin E. Mulder
Arthur M. Govaert
Marrit D. Smit
Janine van Duijn
Amanda C. Foks
Anouk Wezel
Harm J. Smeets
Bram Slütter
Paul H.A. Quax
Johan Kuiper
Ilze Bot
author_sort Eva Kritikou
collection DOAJ
description The presence of mast cells in human atherosclerotic plaques has been associated with adverse cardiovascular events. Mast cell activation, through the classical antigen sensitized-IgE binding to their characteristic Fcε-receptor, causes the release of their cytoplasmic granules. These granules are filled with neutral proteases such as tryptase, but also with histamine and pro-inflammatory mediators. Mast cells accumulate in high numbers within human atherosclerotic tissue, particularly in the shoulder region of the plaque. These findings are largely based on immunohistochemistry, which does not allow for the extensive characterization of these mast cells and of the local mast cell activation mechanisms. In this study, we thus aimed to develop a new flow-cytometry based methodology in order to analyze mast cells in human atherosclerosis. We enzymatically digested 22 human plaque samples, collected after femoral and carotid endarterectomy surgery, after which we prepared a single cell suspension for flow cytometry. We were able to identify a specific mast cell population expressing both CD117 and the FcεR, and observed that most of the intraplaque mast cells were activated based on their CD63 protein expression. Furthermore, most of the activated mast cells had IgE fragments bound on their surface, while another fraction showed IgE-independent activation. In conclusion, we are able to distinguish a clear mast cell population in human atherosclerotic plaques, and this study establishes a strong relationship between the presence of IgE and the activation of mast cells in advanced atherosclerosis. Our data pave the way for potential therapeutic intervention through targeting IgE-mediated actions in human atherosclerosis.
first_indexed 2024-03-12T05:53:46Z
format Article
id doaj.art-b53b9c6c3dfe4dac9cdc26065dd26871
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-12T05:53:46Z
publishDate 2019-04-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-b53b9c6c3dfe4dac9cdc26065dd268712023-09-03T04:56:12ZengMDPI AGCells2073-44092019-04-018433410.3390/cells8040334cells8040334Flow Cytometry-Based Characterization of Mast Cells in Human AtherosclerosisEva Kritikou0Marie A.C. Depuydt1Margreet R. de Vries2Kevin E. Mulder3Arthur M. Govaert4Marrit D. Smit5Janine van Duijn6Amanda C. Foks7Anouk Wezel8Harm J. Smeets9Bram Slütter10Paul H.A. Quax11Johan Kuiper12Ilze Bot13Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The NetherlandsDivision of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The NetherlandsDepartment of Surgery, Leiden University Medical Center, 2333 ZC Leiden, The NetherlandsDivision of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The NetherlandsDepartment of Surgery, Leiden University Medical Center, 2333 ZC Leiden, The NetherlandsDepartment of Surgery, Leiden University Medical Center, 2333 ZC Leiden, The NetherlandsDivision of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The NetherlandsDivision of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The NetherlandsDepartment of Surgery, HMC Westeinde, 2512 VA The Hague, The NetherlandsDepartment of Surgery, HMC Westeinde, 2512 VA The Hague, The NetherlandsDivision of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The NetherlandsDepartment of Surgery, Leiden University Medical Center, 2333 ZC Leiden, The NetherlandsDivision of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The NetherlandsDivision of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The NetherlandsThe presence of mast cells in human atherosclerotic plaques has been associated with adverse cardiovascular events. Mast cell activation, through the classical antigen sensitized-IgE binding to their characteristic Fcε-receptor, causes the release of their cytoplasmic granules. These granules are filled with neutral proteases such as tryptase, but also with histamine and pro-inflammatory mediators. Mast cells accumulate in high numbers within human atherosclerotic tissue, particularly in the shoulder region of the plaque. These findings are largely based on immunohistochemistry, which does not allow for the extensive characterization of these mast cells and of the local mast cell activation mechanisms. In this study, we thus aimed to develop a new flow-cytometry based methodology in order to analyze mast cells in human atherosclerosis. We enzymatically digested 22 human plaque samples, collected after femoral and carotid endarterectomy surgery, after which we prepared a single cell suspension for flow cytometry. We were able to identify a specific mast cell population expressing both CD117 and the FcεR, and observed that most of the intraplaque mast cells were activated based on their CD63 protein expression. Furthermore, most of the activated mast cells had IgE fragments bound on their surface, while another fraction showed IgE-independent activation. In conclusion, we are able to distinguish a clear mast cell population in human atherosclerotic plaques, and this study establishes a strong relationship between the presence of IgE and the activation of mast cells in advanced atherosclerosis. Our data pave the way for potential therapeutic intervention through targeting IgE-mediated actions in human atherosclerosis.https://www.mdpi.com/2073-4409/8/4/334atherosclerosismast cellflow cytometrytryptaseplaque stability
spellingShingle Eva Kritikou
Marie A.C. Depuydt
Margreet R. de Vries
Kevin E. Mulder
Arthur M. Govaert
Marrit D. Smit
Janine van Duijn
Amanda C. Foks
Anouk Wezel
Harm J. Smeets
Bram Slütter
Paul H.A. Quax
Johan Kuiper
Ilze Bot
Flow Cytometry-Based Characterization of Mast Cells in Human Atherosclerosis
Cells
atherosclerosis
mast cell
flow cytometry
tryptase
plaque stability
title Flow Cytometry-Based Characterization of Mast Cells in Human Atherosclerosis
title_full Flow Cytometry-Based Characterization of Mast Cells in Human Atherosclerosis
title_fullStr Flow Cytometry-Based Characterization of Mast Cells in Human Atherosclerosis
title_full_unstemmed Flow Cytometry-Based Characterization of Mast Cells in Human Atherosclerosis
title_short Flow Cytometry-Based Characterization of Mast Cells in Human Atherosclerosis
title_sort flow cytometry based characterization of mast cells in human atherosclerosis
topic atherosclerosis
mast cell
flow cytometry
tryptase
plaque stability
url https://www.mdpi.com/2073-4409/8/4/334
work_keys_str_mv AT evakritikou flowcytometrybasedcharacterizationofmastcellsinhumanatherosclerosis
AT marieacdepuydt flowcytometrybasedcharacterizationofmastcellsinhumanatherosclerosis
AT margreetrdevries flowcytometrybasedcharacterizationofmastcellsinhumanatherosclerosis
AT kevinemulder flowcytometrybasedcharacterizationofmastcellsinhumanatherosclerosis
AT arthurmgovaert flowcytometrybasedcharacterizationofmastcellsinhumanatherosclerosis
AT marritdsmit flowcytometrybasedcharacterizationofmastcellsinhumanatherosclerosis
AT janinevanduijn flowcytometrybasedcharacterizationofmastcellsinhumanatherosclerosis
AT amandacfoks flowcytometrybasedcharacterizationofmastcellsinhumanatherosclerosis
AT anoukwezel flowcytometrybasedcharacterizationofmastcellsinhumanatherosclerosis
AT harmjsmeets flowcytometrybasedcharacterizationofmastcellsinhumanatherosclerosis
AT bramslutter flowcytometrybasedcharacterizationofmastcellsinhumanatherosclerosis
AT paulhaquax flowcytometrybasedcharacterizationofmastcellsinhumanatherosclerosis
AT johankuiper flowcytometrybasedcharacterizationofmastcellsinhumanatherosclerosis
AT ilzebot flowcytometrybasedcharacterizationofmastcellsinhumanatherosclerosis